Arvinas and Pfizer complete Rigel license deal for vepdegestrant
Go back to Arvinas and Pfizer complete Rigel license deal for vepdegestrant| (NASDAQ: ARVN) | Delayed: 8.44 +0.14 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.30 | 52 Week High | $ | |||
| Open | $8.37 | 52 Week Low | $ | |||
| Day High | $8.54 | P/E | N/A | |||
| Day Low | $8.30 | EPS | $ | |||
| Volume | 254,488 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.82 +0.08 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.74 | 52 Week High | $37.39 | |||
| Open | $27.74 | 52 Week Low | $28.25 | |||
| Day High | $28.00 | P/E | 16.86 | |||
| Day Low | $27.49 | EPS | $1.65 | |||
| Volume | 12,682,366 | |||||

